AIDS research and human retroviruses最新文献

筛选
英文 中文
Changes in Bone Mineral Density and Bone Turnover Markers in Antiretroviral Therapy-Naïve People with HIV Starting Bictegravir/Emtricitabine/Tenofovir Alafenamide or Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate. 抗逆转录病毒病毒感染者骨密度和骨转换标志物的变化Therapy-Naïve比替格拉韦/恩曲他滨/替诺福韦阿拉那胺或多拉韦林/拉米夫定/富马酸替诺福韦二氧吡酯。
IF 1 4区 医学
AIDS research and human retroviruses Pub Date : 2026-10-26 DOI: 10.1177/08892229261502015
Leonardo Calza, Maddalena Giglia, Alberto Zuppiroli, Claudio Rigamonti, Domenico Marzolla, Isabella Bon, Pierluigi Viale
{"title":"Changes in Bone Mineral Density and Bone Turnover Markers in Antiretroviral Therapy-Naïve People with HIV Starting Bictegravir/Emtricitabine/Tenofovir Alafenamide or Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate.","authors":"Leonardo Calza, Maddalena Giglia, Alberto Zuppiroli, Claudio Rigamonti, Domenico Marzolla, Isabella Bon, Pierluigi Viale","doi":"10.1177/08892229261502015","DOIUrl":"https://doi.org/10.1177/08892229261502015","url":null,"abstract":"<p><p>Antiretroviral therapy (ART), including tenofovir disoproxil fumarate (TDF), has been associated with an increased risk of bone loss in people living with HIV (PLWH) compared with tenofovir alafenamide (TAF). However, there is no direct comparison about changes in bone mineral density (BMD) between the initial fixed-drug combination bictegravir/emtricitabine/TAF (BIC/F/TAF) and doravirine/lamivudine/TDF (DOR/3TC/TDF). A retrospective, observational, cohort study was conducted of PLWH aged >40 years who started an initial ART, including BIC/F/TAF or DOR/3TC/TDF, and underwent dual-energy X-ray absorptiometry (DXA) before ART initiation. BMD changes and variations in bone turnover markers (bone alkaline phosphatase and beta-crosslaps) were evaluated in participants who had follow-up DXA scans after ≥12 months of ART. As a whole, 72 persons (61 males, mean age 48.6 years) were enrolled: 39 starting BIC/F/TAF and 33 DOR/3TC/TDF. At baseline, 13 subjects (18%) were diagnosed with low BMD (T-score < -1.0 or Z-score < -2.0), without significant differences between groups. After a median follow-up of 14.3 months, decreases in median absolute BMD were comparable between groups. The median reduction (IQR) in BMD at the femur neck was -0.03 (-0.07, 0.00) g/cm<sup>2</sup> in the BIC/F/TAF group and -0.04 (-0.08, -0-01) g/cm<sup>2</sup> in DOR/3TC/TDF group (<i>p</i> = .177). The median change (IQR) in BMD at the lumbar spine was -0.04 (-0.08, 0.00) g/cm<sup>2</sup> in BIC/F/TAF group and -0.05 (-0.09, -0-01) g/cm<sup>2</sup> in the DOR/3TC/TDF group (<i>p</i> = .245). Changes in bone turnover markers were also comparable between groups. In our study, initial antiretroviral regimen with BIC/F/TAF or DOR/3TC/TDF caused comparable reduction in BMD and similar changes in bone turnover markers.</p>","PeriodicalId":7544,"journal":{"name":"AIDS research and human retroviruses","volume":" ","pages":"8892229261502015"},"PeriodicalIF":1.0,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149260700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hospitalization Patterns Among People Living with HIV During India's Transition to Universal Antiretroviral Therapy Access, 2013-2017. 2013-2017年印度向普遍抗逆转录病毒治疗过渡期间艾滋病毒感染者住院模式
IF 1 4区 医学
AIDS research and human retroviruses Pub Date : 2026-10-23 DOI: 10.1177/08892229261500900
Amyeo Afroz Jereen, Celia Vitale Kucera, Saniya Pervin, Muralidhar Varma, Rajesh Radhakrishnan, Ambuj Kumar, Seetha Lakshmi, Lynette Menezes
{"title":"Hospitalization Patterns Among People Living with HIV During India's Transition to Universal Antiretroviral Therapy Access, 2013-2017.","authors":"Amyeo Afroz Jereen, Celia Vitale Kucera, Saniya Pervin, Muralidhar Varma, Rajesh Radhakrishnan, Ambuj Kumar, Seetha Lakshmi, Lynette Menezes","doi":"10.1177/08892229261500900","DOIUrl":"https://doi.org/10.1177/08892229261500900","url":null,"abstract":"<p><p>India has 2.6 million people living with human immunodeficiency virus (HIV) (PLWHIV) yet remains underrepresented in global hospitalization analyses. This study characterizes hospitalization patterns during India's transition toward universal antiretroviral therapy (ART) access (2013-2017) and quantifies the protective effect of sustained ART against acquired immunodeficiency syndrome (AIDS)-defining hospitalizations. A retrospective cohort study of HIV-positive patients aged ≥18 years admitted to a tertiary care center in Manipal, India was performed. Primary hospitalization reasons were categorized as AIDS-defining illness, HIV-associated non-AIDS (HANA), or non-HANA conditions. Multivariable logistic regression estimated associations between ART duration (≥9 vs. <9 months) and AIDS-defining hospitalization. Among 1,280 patients (2,157 admissions), median age was 44 years, 68% were male, and 46% were newly diagnosed at admission. AIDS-defining illnesses accounted for 45% of admissions, with tuberculosis being most prevalent (18%). Patients receiving ART ≥9 months had significantly lower odds of AIDS-defining hospitalization (adjusted odds ratio 0.78, 95% confidence interval 0.61-0.99). AIDS-defining illnesses, particularly tuberculosis, remain the predominant cause of HIV-related hospitalization in India. The high proportion of new diagnoses at admission and protective effect of sustained ART underscore the need for earlier HIV testing, rapid ART initiation, and adherence support.</p>","PeriodicalId":7544,"journal":{"name":"AIDS research and human retroviruses","volume":" ","pages":"8892229261500900"},"PeriodicalIF":1.0,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149242479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Willingness to Participate in HIV Cure Research Among Young People Living with Perinatally Acquired HIV in the Centre Region of Cameroon: A Cross-Sectional Survey. 喀麦隆中部地区围产期感染艾滋病毒的年轻人参与艾滋病毒治疗研究的意愿:一项横断面调查。
IF 1 4区 医学
AIDS research and human retroviruses Pub Date : 2026-10-07 DOI: 10.1177/08892229261495198
Aude Christelle Ka'e, Yagai Bouba, Rita Ekwoge, Ali Ahmed, Lum Forgwei, Tatiana Tekoh, Cynthia Ayafor, Laurel Tchamda, Sonia Teneneg Nek, Forgu Esemu Livo, Naomi-Karell Etame, Suzie Tetang, Catherine Eyenga, Alex Durand Nka, Annie Carole Nga Motaze, Francois Ateba, Ezechiel Ngoufack Jagni Semengue, Collins Ambe Chenwi, Aubin Nanfack, Celine Nkenfou, Illiassou Mfochive, Marcel Tongo, Maria Mercedes Santoro, Francesca Ceccherini-Silberstein, Gianluca Russo, Alexis Ndjolo, Carlo-Federico Perno, Caroline T Tiemessen, Krista L Dong, Deborah Persaud, Thumbi Ndung'u, Jessica Salzwedel, Stefano D'Amelio, Karine Dubé, Joseph Fokam
{"title":"Willingness to Participate in HIV Cure Research Among Young People Living with Perinatally Acquired HIV in the Centre Region of Cameroon: A Cross-Sectional Survey.","authors":"Aude Christelle Ka'e, Yagai Bouba, Rita Ekwoge, Ali Ahmed, Lum Forgwei, Tatiana Tekoh, Cynthia Ayafor, Laurel Tchamda, Sonia Teneneg Nek, Forgu Esemu Livo, Naomi-Karell Etame, Suzie Tetang, Catherine Eyenga, Alex Durand Nka, Annie Carole Nga Motaze, Francois Ateba, Ezechiel Ngoufack Jagni Semengue, Collins Ambe Chenwi, Aubin Nanfack, Celine Nkenfou, Illiassou Mfochive, Marcel Tongo, Maria Mercedes Santoro, Francesca Ceccherini-Silberstein, Gianluca Russo, Alexis Ndjolo, Carlo-Federico Perno, Caroline T Tiemessen, Krista L Dong, Deborah Persaud, Thumbi Ndung'u, Jessica Salzwedel, Stefano D'Amelio, Karine Dubé, Joseph Fokam","doi":"10.1177/08892229261495198","DOIUrl":"https://doi.org/10.1177/08892229261495198","url":null,"abstract":"<p><p>Young people living with perinatally acquired HIV (YPLHIV) represent a unique population for HIV cure research, offering opportunities to assess interventions in a group for whom adherence to antiretroviral treatment (ART) is particularly challenging. Understanding their perspectives about participating in HIV cure research could inform the design of future YPLHIV-centered study protocols. In this cross-sectional study, we assessed awareness and willingness to engage in HIV cure research among YPLHIV in Cameroon from February to April 2025. A questionnaire was administered to 157 YPLHIV [50.7% male; median (interquartile range) age: 18(16-20) years]; 83.6% were attending secondary school, and 9.6% were living in rural settings with 145 (92.3%) full respondents. The majority (63.0%) were aware that HIV cure research is being conducted (3.3% of them from rural vs. 96.7% from urban settings, <i>p</i> = .093); with awareness higher among secondary-school students (94.6%; <i>p</i> = .029), and those having internet access (77.2% vs. 21.7% for others; <i>p</i> = .032). The understanding of HIV \"cure\" included: \"no more treatment needed\" (31.2%), \"elimination of the virus\" (16.0%), and \"no longer having the disease\" (7.6%). Almost 90% were apparently willing to participate in cure research across sex, educational level, adherence, and geographical settings, with 44/145 (30.3%) reporting at least one concern about participation, such as \"collection of many samples\" (10/145; 6.90%). The main motivation to participate was the \"possibilities of finding a cure\" (28.7%). While over 60% were aware of ongoing HIV cure research, efforts to improve awareness are needed in rural settings. Identifying challenges perceived by YPLHIV offers a guide for developing tailored communication and support. The high presumed willingness of YPLHIV to participate in HIV cure research offers promise for implementation in Cameroon and similar settings across Africa, where YPLHIV need alternatives to daily ART. However, further research into informed willingness and actual real-world clinical trial participation will be essential to determine overall feasibility and implementation success.</p>","PeriodicalId":7544,"journal":{"name":"AIDS research and human retroviruses","volume":" ","pages":"8892229261495198"},"PeriodicalIF":1.0,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149126173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-Traumatic Stress Symptoms Related to the COVID-19 Pandemic in Persons Living and Aging with HIV. 艾滋病毒感染者和老年感染者中与COVID-19大流行相关的创伤后应激症状
IF 1 4区 医学
AIDS research and human retroviruses Pub Date : 2026-10-01 Epub Date: 2026-07-23 DOI: 10.1177/08892229261472161
Sharon Walmsley, Majid Mabipoor, Alan Wai, Curtis Cooper, Bryan Boyachuk, Mona Loutfy, Marina Klein
{"title":"Post-Traumatic Stress Symptoms Related to the COVID-19 Pandemic in Persons Living and Aging with HIV.","authors":"Sharon Walmsley, Majid Mabipoor, Alan Wai, Curtis Cooper, Bryan Boyachuk, Mona Loutfy, Marina Klein","doi":"10.1177/08892229261472161","DOIUrl":"10.1177/08892229261472161","url":null,"abstract":"<p><p>The COVID-19 pandemic was an event involving an actual threat of death, serious injury, or harm to the integrity of self or others, which could have served as a precipitant for unmasking symptoms of post-traumatic stress disorder (PTSD). Persons living with HIV and those with hepatitis C (HCV) coinfection could be at increased risk of PTSD symptoms after a traumatic event, given their lifetime experiences of trauma, stigma, poverty, mental health conditions, and substance use. We measured PTSD symptoms at three time points during the COVID-19 pandemic using a 17-item questionnaire in two established cohorts of persons living with HIV in Canada-those with HCV coinfection and those aging with HIV-groups at risk for having symptoms. We found that twice as many persons in the HCV coinfection cohort had moderate to severe PTSD symptoms at baseline relative to the aging cohort (49% vs. 25%) and that these percentages remained high in the coinfection cohort but declined in the aging cohort with time. Notably, those who self-reported depression had increased rates of PTSD symptoms over time. Our data points to the potential long-lasting impact that the COVID-19 pandemic or other traumatic events could have on the mental health of persons living with HIV and those with coinfection, especially among those with underlying depression. We stress the need for increased awareness and management strategies of vulnerable groups during times of trauma.</p>","PeriodicalId":7544,"journal":{"name":"AIDS research and human retroviruses","volume":" ","pages":"286-297"},"PeriodicalIF":1.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148576474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Provider Preferences on Existing and Potential Future Biomedical HIV Prevention Products: A Qualitative Study in the United States, Thailand, and South Africa. 提供者对现有和潜在的未来生物医学HIV预防产品的偏好:美国、泰国和南非的定性研究。
IF 1 4区 医学
AIDS research and human retroviruses Pub Date : 2026-10-01 Epub Date: 2026-08-24 DOI: 10.1177/08892229261480775
Christine Tagliaferri Rael, Doyel Das, Rebecca Giguere, Jonathan Porter, Ewa Bryndza Tfaily, Camagu Tuswa Haynes, Titcha Ho, Stacey McKenna, Javier Lopez-Ríos, Cody Lentz, Curtis Dolezal, Samantha Stonbraker, Craig Hendrix, Richard T D'Aquila, Thomas J Hope
{"title":"Provider Preferences on Existing and Potential Future Biomedical HIV Prevention Products: A Qualitative Study in the United States, Thailand, and South Africa.","authors":"Christine Tagliaferri Rael, Doyel Das, Rebecca Giguere, Jonathan Porter, Ewa Bryndza Tfaily, Camagu Tuswa Haynes, Titcha Ho, Stacey McKenna, Javier Lopez-Ríos, Cody Lentz, Curtis Dolezal, Samantha Stonbraker, Craig Hendrix, Richard T D'Aquila, Thomas J Hope","doi":"10.1177/08892229261480775","DOIUrl":"10.1177/08892229261480775","url":null,"abstract":"<p><p>Several forms of HIV pre-exposure prophylaxis (PrEP) are approved, prescribed off-label, or in development in the United States, including daily oral tablets, long-acting injectable cabotegravir (CAB-LA), removable implants, and rectal tenofovir products. To understand how health care providers prioritize among these options, 30 providers from the United States, Thailand, and South Africa completed online surveys, and 10 participated in in-depth interviews. Providers shared their perspectives on current and emerging PrEP products, key informational needs for gay and bisexual men, and preferred educational strategies. When asked to rank PrEP options if all were simultaneously available, providers most often prioritized removable implants (<i>N</i> = 3), daily oral PrEP (<i>N</i> = 3), CAB-LA (<i>N</i> = 1), and rectal douches/enemas (<i>N</i> = 1), while others (<i>N</i> = 2) emphasized patient preference. Overall, providers noted that each product has unique advantages and expressed support for digital shared decision-making tools to enhance patient-provider communication about PrEP selection.</p>","PeriodicalId":7544,"journal":{"name":"AIDS research and human retroviruses","volume":" ","pages":"307-317"},"PeriodicalIF":1.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148811699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in HIV/AIDS Knowledge and Self-Testing Preferences Among College Students: A Five-Year Repeated Cross-Sectional Survey in Shenzhen, China. 深圳市大学生艾滋病知识与自检倾向趋势:一项为期5年的重复横断面调查
IF 1 4区 医学
AIDS research and human retroviruses Pub Date : 2026-10-01 Epub Date: 2026-08-20 DOI: 10.1177/08892229261479805
Anqi Song, Haohang Wang, Runlong Fan, Junqi Liu, Yu Liao, Di Yin, Nan Wu, Wei Ye, Caijun Sun, Jianhui Yuan
{"title":"Trends in HIV/AIDS Knowledge and Self-Testing Preferences Among College Students: A Five-Year Repeated Cross-Sectional Survey in Shenzhen, China.","authors":"Anqi Song, Haohang Wang, Runlong Fan, Junqi Liu, Yu Liao, Di Yin, Nan Wu, Wei Ye, Caijun Sun, Jianhui Yuan","doi":"10.1177/08892229261479805","DOIUrl":"10.1177/08892229261479805","url":null,"abstract":"<p><p>Despite over 40 years having passed since the discovery of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), neither a cure nor a prophylactic vaccine is yet clinically available. Promoting preventive measures and raising awareness remain critical to controlling the epidemic, especially among key populations such as college students and men who have sex with men (MSM), particularly in light of the rapid rise in adolescent AIDS cases in China. In this study, we conducted an annual anonymous online cross-sectional survey from 2018 to 2022 to assess HIV/AIDS-related knowledge and willingness to adopt preventive measures among college students in Shenzhen, China. A total of 3,095 valid questionnaires were collected. The knowledge attainment rate increased significantly from 28.2% to 49.5% during this period and was correlated with gender, age, grade, and household registration status (<i>p</i> < .05). Male participants (odds ratio = 1.232, 95% confidence interval: 1.053-1.422, <i>p</i> < .01) demonstrated higher HIV/AIDS knowledge awareness than females and were more willing to use self-testing. Fingerstick blood-based self-test kits were the most commonly preferred option among participants. Most participants preferred to access self-test kits in medical rooms, dormitories, and bathrooms. Although MSM individuals showed greater willingness to adopt preventive measures, their knowledge awareness rate was not significantly different from that of the general student population. These findings suggest that implementing peer-community health programs combined with edutainment approaches may improve HIV/AIDS knowledge and promote preventive behaviors and service utilization among college students.</p>","PeriodicalId":7544,"journal":{"name":"AIDS research and human retroviruses","volume":" ","pages":"298-306"},"PeriodicalIF":1.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148787119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Albuvirtide Plus Dolutegravir or Dolutegravir/Lamivudine in Hospitalized People with Advanced AIDS: A Retrospective Real-World Study. 阿尔韦肽联合多替格拉韦或多替格拉韦/拉米夫定治疗晚期艾滋病住院患者的疗效和安全性:一项回顾性现实世界研究
IF 1 4区 医学
AIDS research and human retroviruses Pub Date : 2026-10-01 Epub Date: 2026-08-10 DOI: 10.1177/08892229261394656
Huanxia Liu, Yuanhong He, Tongtong Yang, Lin Cai, Yuan Yuan, Chunrong Lv, Shenghua He
{"title":"Efficacy and Safety of Albuvirtide Plus Dolutegravir or Dolutegravir/Lamivudine in Hospitalized People with Advanced AIDS: A Retrospective Real-World Study.","authors":"Huanxia Liu, Yuanhong He, Tongtong Yang, Lin Cai, Yuan Yuan, Chunrong Lv, Shenghua He","doi":"10.1177/08892229261394656","DOIUrl":"10.1177/08892229261394656","url":null,"abstract":"<p><p>Hospitalized people with advanced AIDS require potent, safe antiretroviral therapy (ART) with minimal drug interactions. This real-world retrospective cohort study aims to evaluate the efficacy and safety of albuvirtide (ABT) plus dolutegravir (DTG), with or without lamivudine (3TC), in this vulnerable population. We retrospectively analyzed clinical data from treatment-naïve (TN) and treatment-experienced (TE) hospitalized people with AIDS who received an ABT-based regimen for at least 24 weeks at the Chengdu Public Health Clinical Medical Center between July 2021 and July 2023. The primary outcome was the virological suppression rate (HIV-1 RNA <50 copies/mL) at week 24. A total of 174 patients (112 TN, 62 TE) were included, with 90.23% presenting with opportunistic infections. At week 24, the overall virological suppression rate was 79.89% (139/174). The suppression rate was 75.89% in TN patients and 87.10% in TE patients. From baseline, the median CD4 count increased by 115.50 cells/μL in the TN group and 89.00 cells/μL in the TE group (both <i>p</i> < .05). Treatment-related adverse events (AEs) occurred in only 5.17% of patients, all were mild-to-moderate, and no injection-site reactions were reported. No significant differences in efficacy or safety were found between the ABT + DTG and ABT + DTG/3TC regimens. In a real-world setting, ABT-based regimens containing DTG (with or without 3TC) demonstrated high efficacy and excellent safety in hospitalized people with advanced AIDS, supporting its use in this difficult-to-treat population.</p>","PeriodicalId":7544,"journal":{"name":"AIDS research and human retroviruses","volume":" ","pages":"279-285"},"PeriodicalIF":1.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148705462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sequence Notes: Identification of a Novel HIV-1 Circulating Recombinant Form (CRF200_0755) in a Southern Border Region of Yunnan, China. 序列注释:在中国云南南部边境地区鉴定了一种新的HIV-1循环重组形式(CRF200_0755)。
IF 1 4区 医学
AIDS research and human retroviruses Pub Date : 2026-10-01 Epub Date: 2026-07-10 DOI: 10.1177/08892229261469040
Min Chen, Huichao Chen, Yanling Ma, Wenfei Ding, Manhong Jia
{"title":"Sequence Notes: Identification of a Novel HIV-1 Circulating Recombinant Form (CRF200_0755) in a Southern Border Region of Yunnan, China.","authors":"Min Chen, Huichao Chen, Yanling Ma, Wenfei Ding, Manhong Jia","doi":"10.1177/08892229261469040","DOIUrl":"10.1177/08892229261469040","url":null,"abstract":"<p><p>The long-term co-circulation of various HIV-1 subtypes and circulating recombinant forms (CRFs) in China has created an environment conducive to viral recombination. This study identified a novel HIV-1 CRF resulting from the recombination of CRF07_BC and CRF55_01B in Xishuangbanna Prefecture, Yunnan Province. Nearly full-length HIV-1 genome sequences were obtained from three individuals with no epidemiological link, including two men who have sex with men and one individual with heterosexual contact. These individuals were reported in 2023. These sequences form a monophyletic clade that is distinct from all known subtypes and CRFs. Recombination and phylogenetic analyses revealed that this recombinant strain exhibited a consistent mosaic genomic structure, with the CRF55_01B backbone incorporating two CRF07_BC segments. Bayesian phylogenetic analyses indicated that this recombinant form originated around 2019. In accordance with standard nomenclature, it has been designated CRF200_0755. In addition, this recombinant strain carries the V179E resistance mutation from CRF55_01B. The discovery of this novel CRF highlights the ongoing evolution of HIV-1 amid the co-circulation of prevalent strains and population mobility. It also emphasizes the importance of continuous molecular surveillance in guiding public health strategies, given the potential presence of preexisting resistance mutations.</p>","PeriodicalId":7544,"journal":{"name":"AIDS research and human retroviruses","volume":" ","pages":"318-322"},"PeriodicalIF":1.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148417974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genomic Characterization of Two Novel HIV-1 CRF01_AE/CRF07_BC Unique Recombinant Forms in Shenzhen, China. 深圳两种新型HIV-1 CRF01_AE/CRF07_BC独特重组形式的基因组特征
IF 1 4区 医学
AIDS research and human retroviruses Pub Date : 2026-10-01 Epub Date: 2026-07-23 DOI: 10.1177/08892229261471606
Dandan Lin, Bo Zhu, Shengya Liu, Chang Lu, Pinghui Wu, Borong Wen, Binglou He, Hanping Li, Yongjian Liu, Lei Jia, Bohan Zhang, Xiaolin Wang, Jingyun Li, Jingwan Han, Junjun Jiang, Lin Li
{"title":"Genomic Characterization of Two Novel HIV-1 CRF01_AE/CRF07_BC Unique Recombinant Forms in Shenzhen, China.","authors":"Dandan Lin, Bo Zhu, Shengya Liu, Chang Lu, Pinghui Wu, Borong Wen, Binglou He, Hanping Li, Yongjian Liu, Lei Jia, Bohan Zhang, Xiaolin Wang, Jingyun Li, Jingwan Han, Junjun Jiang, Lin Li","doi":"10.1177/08892229261471606","DOIUrl":"10.1177/08892229261471606","url":null,"abstract":"<p><p>Recombination events are a key driver of human immunodeficiency virus type 1 (HIV-1) genetic diversity. In this study, HIV-1 samples were collected from two male patients in Shenzhen, China. Two novel recombinant forms (Ls6449 and Ls16801) derived from CRF01_AE and CRF07_BC were identified, and their near full-length genomes were obtained. Analysis of these two forms suggested that the recombination between CRF01_AE and CRF07_BC continued to occur in Shenzhen, potentially contributing to the increasing genetic complexity of the local HIV-1 epidemic. These findings highlight the need for enhanced molecular surveillance and genotyping targeting key routes, specifically sexual transmission and mobility-associated spread. It is expected to generate precise epidemiological evidence and inform local HIV prevention and control strategies.</p>","PeriodicalId":7544,"journal":{"name":"AIDS research and human retroviruses","volume":" ","pages":"323-330"},"PeriodicalIF":1.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148576246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perceived Ethical Risks of HIV Phylogenetic Research: Insights from Professional Stakeholders in Uganda. HIV系统发育研究的感知伦理风险:来自乌干达专业利益相关者的见解。
IF 1 4区 医学
AIDS research and human retroviruses Pub Date : 2026-08-01 Epub Date: 2026-06-02 DOI: 10.1177/08892229261455943
Farirai Mutenherwa, Tom Lutalo, Ronald M Galiwango, Jennifer Brophy Feltes, Jade Jackson, Oliver Laeyendecker, Nelson K Sewankambo, Jeremy Sugarman, Mary Kate Grabowski
{"title":"Perceived Ethical Risks of HIV Phylogenetic Research: Insights from Professional Stakeholders in Uganda.","authors":"Farirai Mutenherwa, Tom Lutalo, Ronald M Galiwango, Jennifer Brophy Feltes, Jade Jackson, Oliver Laeyendecker, Nelson K Sewankambo, Jeremy Sugarman, Mary Kate Grabowski","doi":"10.1177/08892229261455943","DOIUrl":"10.1177/08892229261455943","url":null,"abstract":"<p><p>HIV phylogenetics is a powerful tool for elucidating HIV transmission dynamics, but ethical concerns have been raised about its use. We conducted a cross-sectional online survey among HIV professional stakeholders in Uganda to explore their knowledge of HIV phylogenetics and associated ethical considerations. Thirty-two participants completed the survey. 87% correctly defined HIV phylogenetics, but some were unable to recognize potential individual harms associated with HIV phylogenetic research (HPR). The most common individual and societal harms of HPR recognized were identification as an HIV transmission source 25 (78%; 95% CI, 61-89%) and marginalization of certain groups 27 (84%; 95% CI, 68-93%), respectively. Most strongly agreed that obtaining community assent 17 (53%; 95% CI, 36-69%) and specific informed consent for viral sequences used in HPR 20 (63%; 95% CI, 45-77%) were critical. Risks associated with HPR appear to be incompletely understood, underscoring the need to raise awareness of them among various professional stakeholders.</p>","PeriodicalId":7544,"journal":{"name":"AIDS research and human retroviruses","volume":" ","pages":"260-263"},"PeriodicalIF":1.0,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13643410/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148142435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书